Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA Advisory Committee to review Marqibo in December

Sep. 29, 2004

Enrollment open in phase I study of AQ4N

Sep. 29, 2004

Novel steryl sulfatase inhibitors discovered at Kyowa Hakko

Sep. 29, 2004

Novel oligoadenylic acid derivatives for use in cancer and viral infections

Sep. 29, 2004

Novel GnRH antagonists in early development at Takeda

Sep. 29, 2004

Enrollment under way in Modrenal prostate cancer study

Sep. 28, 2004

Alimta approved in Europe for malignant pleural mesothelioma and NSCLC

Sep. 28, 2004

Sopherion licenses North American rights to Myocet

Sep. 28, 2004

New antitumor agents and their use in ALL therapy

Sep. 28, 2004

Pharmion's MAA for Vidaza accepted for review by EMEA

Sep. 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...